cyclopentane has been researched along with fosbretabulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, SK; Borate, HB; Burman, AC; Chaudhary, A; Dutt, S; Dutta, K; Gurjar, MK; Jadhav, VH; Jaggi, M; Krishnan, K; Mahajan, VA; Mukherjee, R; Rajendran, P; Sanna, VK; Shinde, PD; Singh, AT; Singh, G; Singh, MK; Srivastava, SK; Verma, R; Wakharkar, RD | 1 |
| Baskaran, S; Gouse, S; Reddy, NR; Selvaraju, S | 1 |
2 other study(ies) available for cyclopentane and fosbretabulin
| Article | Year |
|---|---|
Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclopentanes; DNA Fragmentation; Drug Screening Assays, Antitumor; Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Solubility; Stilbenes; Structure-Activity Relationship; Transplantation, Heterologous; Tubulin Modulators | 2007 |
Domino Semipinacol/Iterative Aldol/Iso-Nazarov Cyclization to Triaryl-cyclopentenone: Enantioselective Synthesis of Combretastatin A-4 Analogues.
Topics: Aldehydes; Cyclization; Cyclohexenes; Cyclopentanes; Stereoisomerism; Stilbenes | 2022 |